B2M and anemia: According to univariate analysis, we found that the age group, serum creatinine, beta-2 microglobulin level at diagnosis, treatment with ASCT, receiving novel agents, response to first-line therapy for at least VGPR, and complication after treatment with anemia or SRE emerged as significant factors for OS.